Sitafloxacin
From Wikipedia, the free encyclopedia
 |
|
|---|---|
| Systematic (IUPAC) name | |
| 7- [(4S)- 4-amino- 6-azaspiro [2.4] heptan- 6-yl]- 8-chloro- 6-fluoro- 1- [(2S)- 2-fluorocyclopropyl]- 4-oxoquinoline- 3-carboxylic acid | |
| Clinical data | |
| Pregnancy cat. | ? |
| Legal status | ℞ Prescription only |
| Routes | Oral |
| Identifiers | |
| CAS number | 127254-12-0  |
| ATC code | J01MA21 |
| PubChem | CID 461399 |
| ChemSpider | 405945  |
| UNII | 3GJC60U4Q8 |
| ChEMBL | CHEMBL108821 |
| Chemical data | |
| Formula | C19H18ClF2N3O3 |
| Mol. mass | 409.81 |
| SMILES | eMolecules & PubChem |
|
|
 (what is this?) (verify) |
|
Sitafloxacin (INN; also called DU-6859a) is a fluoroquinolone antibiotic[1] that shows promise in the treatment of Buruli ulcer. The molecule was identified by Daiichi Sankyo Co., which brought ofloxacin and levofloxacin to the market. Sitafloxacin is currently marketed in Japan by Daiichi Sankyo under the tradename Gracevit.
[edit] See also
[edit] References
- ^ Anderson, DL. (Jul 2008). "Sitafloxacin hydrate for bacterial infections.". Drugs Today (Barc) 44 (7): 489–501. doi:10.1358/dot.2008.44.7.1219561. PMID 18806900.
- (Japanese) Gracevit グレースビット (PDF) Daiichi Sankyo Co. January 2008.
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
 |
This systemic antibacterial-related article is a stub. You can help Wikipedia by expanding it. |
